The Effect of Solvents and Drying Temperature on the Physicochemical Properties of Darunavir and Darunavir Ethanolate Substances
| Autor: | I. A. Dain, S. A. Zolotov, N. B. Demina, A. S. Zolotova, E. S. Ponomarev |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2021 |
| Předmět: |
solid dosage form technology
darunavir ethanolate Chromatography Chemistry x-ray powder diffraction Pharmaceutical Science darunavir hplc Darunavir ethanolate solvates Drug Discovery medicine differential scanning calorimetry ir spectroscopy HD9665-9675 Darunavir pseudopolymorphism Pharmaceutical industry medicine.drug |
| Zdroj: | Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 67-73 (2021) |
| ISSN: | 2658-5049 2305-2066 |
| Popis: | Introduction. Usage of aggressive conditions (solvents, high temperature, etc.) in a dosage form manufacturing can lead to a change in the properties of a pharmaceutical substance. Darunavir (D) amorphous and darunavir ethanolate (DE) crystalline both have poor solubility, ability to pseudopolymorphism and are sensitive to high temperatures.Aim. Study the effect of solvents and drying temperature on the physicochemical properties of D and DE substancesMaterials and methods. D (Mylan Laboratories Limited), DE (Mylan Laboratories Limited), D (reference standard) 99,9 % (MSN Pharmachem Private Limited). D and DE weighed quantity was suspended in one of the solvents via magnetic stirrer and was dried via universal oven. Powder X-ray diffraction of dried samples was carried out via automatic powder diffractometer. Using DSC thermal properties of the samples were studied. Crystalline samples were examined using IR spectroscopy. Identification of D and DE was performed by HPLC method.Results and discussion. This article summarizes study results of the investigation of various solvents and drying temperature influence on the physicochemical properties of D and DE are presented. The impact of solvent type and drying temperatures in physicochemical properties of the APIs was studied by X-ray powder diffraction, differential scanning calorimetry, IR spectroscopy and HPLC methods. It was shown, that solvent type and drying temperatures can result in the presence of crystalline D solvates or amorphous D.Conclusion. To obtain the final drug containing as an API amorphous D, which perform better dissolution, one of the enlisted solvents can be used: dichloromethane, chloroform and heptane. In such case the intermediate product drying should be performed at not exceeding the solvent boiling point temperatures. In case of ethanol, methanol, acetone and tetrahydrofuran drying phase can be performed at temperatures, that are higher than melting points of obtained pseudopolymorphs. For the utilization of DE as an API only ethanol usage is efficient and drying temperature should not exceed 73.4 °C. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|